Literature DB >> 22359101

Ectoenzymes controlling leukocyte traffic.

Marko Salmi1, Sirpa Jalkanen.   

Abstract

Ectoenzymes are a diverse group of membrane proteins that have their catalytic sites outside the plasma membrane. Many of them are found on leukocytes and endothelial cells, and they are multifunctional in nature. Collectively, different ectoenzymes can modulate each step of leukocyte-endothelial contacts, as well as subsequent cell migration in tissues. Here, we review how ectoenzymes belonging to the oxidase, NAD-metabolizing enzyme, nucleotidase and peptidase/protease families regulate and fine-tune leukocyte trafficking, and how ectoenzymes have been targeted both in preclinical and clinical trials.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359101     DOI: 10.1002/eji.201142223

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Binding of CD157 protein to fibronectin regulates cell adhesion and spreading.

Authors:  Simona Morone; Stefania Augeri; Massimiliano Cuccioloni; Matteo Mozzicafreddo; Mauro Angeletti; Nicola Lo Buono; Alice Giacomino; Erika Ortolan; Ada Funaro
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

Review 2.  Ectoenzymes in leukocyte migration and their therapeutic potential.

Authors:  Marko Salmi; Sirpa Jalkanen
Journal:  Semin Immunopathol       Date:  2014-03-18       Impact factor: 9.623

3.  Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.

Authors:  Christian Carpéné; Francisco Les; Mounia Hasnaoui; Simon Biron; Picard Marceau; Denis Richard; Jean Galitzky; Denis R Joanisse; Pascale Mauriège
Journal:  J Physiol Biochem       Date:  2016-10-21       Impact factor: 4.158

4.  Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice.

Authors:  Ping Hu; Jeffrey S Thinschmidt; Sergio Caballero; Samuel Adamson; Louise Cole; Tailoi Chan-Ling; Maria B Grant
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-24       Impact factor: 4.310

5.  Structural comparison of the active site channels in rodent and primate vascular adhesion protein-1.

Authors:  Eva Bligt-Lindén; Ramaiah Arunachalam; Vimal Parkash; Tiina Annamaria Salminen
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

Review 6.  Targeting cells in motion: migrating toward improved therapies.

Authors:  Jason W Griffith; Andrew D Luster
Journal:  Eur J Immunol       Date:  2013-05-13       Impact factor: 5.532

Review 7.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

8.  Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode.

Authors:  Eva Bligt-Lindén; Marjo Pihlavisto; István Szatmári; Zbyszek Otwinowski; David J Smith; László Lázár; Ferenc Fülöp; Tiina A Salminen
Journal:  J Med Chem       Date:  2013-12-13       Impact factor: 7.446

9.  Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.

Authors:  Ali Munaim Yousif; Michele Minopoli; Katia Bifulco; Vincenzo Ingangi; Gioconda Di Carluccio; Francesco Merlino; Maria Letizia Motti; Paolo Grieco; Maria Vincenza Carriero
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

10.  Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate.

Authors:  Heli Elovaara; Teija Huusko; Mikael Maksimow; Kati Elima; Gennady G Yegutkin; Mikael Skurnik; Ulrich Dobrindt; Anja Siitonen; Michael J McPherson; Marko Salmi; Sirpa Jalkanen
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.